Crsp stock price nasdaq
WebCRISPR Therapeutics AG Common Shares (CRSP) Nasdaq Listed 0 Add to Watchlist Add to Portfolio CRSP CRSP INSTITUTIONAL HOLDINGS CRSP Institutional Holdings … WebApr 13, 2024 · CRSP Earnings Date and Information. CRISPR Therapeutics last posted its earnings results on February 21st, 2024. The reported ($1.41) EPS for the quarter, beating the consensus estimate of ($2.27) by $0.86. The business earned $6 million during the quarter, compared to analyst estimates of $7.37 million.
Crsp stock price nasdaq
Did you know?
Web1 day ago · InvestorPlace - Stock Market News, Stock Advice & Trading Tips Against the backdrop of a solid day on Wall Street, CRISPR Therapeutics (NASDAQ: CRSP ) distinguished itself, popping up nearly 16%. WebApr 12, 2024 · View CRISPR Therapeutics AG CRSP investment & stock information. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
WebGet the latest CRSP US Total Market Index (CRSPTM1) value, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebFeb 1, 2024 · The Center for Research in Security Prices, LLC (CRSP) maintains the most comprehensive collection of security price, return, and volume data for the NYSE, AMEX and NASDAQ stock markets. Additional CRSP files provide stock indices, beta-based and cap-based portfolios, treasury bond and risk-free rates, mutual funds, and real …
WebApr 15, 2024 · Chardan Capital dropped their price target on shares of CRISPR Therapeutics from $153.00 to $123.00 and set a “buy” rating on the stock in a research report on Wednesday, February 22nd. WebSep 17, 2024 · Since being added to the Focus List on May 18, 2024 at $109.22 per share, shares of CRSP have increased 7.51% to $117.42. The stock is currently a #3 (Hold) on the Zacks Rank. Four analysts...
Web1 day ago · The upgrade coincides with a draft report from the drug pricing watchdog, Institute for Clinical and Economic Review (ICER) that estimated a $1.9M price tag for exa-cel and a rival sickle cell ...
WebApr 14, 2024 · April 14, 2024, 3:13 AM · 2 min read CRISPR Therapeutics AG CRSP shares soared 16.3% in the last trading session to close at $50.56. The move was backed by solid volume with far more shares... game store hazyview contact numberWebApr 6, 2024 · Analyst Price Forecast Suggests 97.56% Upside As of April 6, 2024, the average one-year price target for Crispr Therapeutics is $85.88. The forecasts range from a low of $39.39 to a high of $231.00. game store head office contact numberWebApr 6, 2024 · According to the issued ratings of 18 analysts in the last year, the consensus rating for CRISPR Therapeutics stock is Hold based on the current 1 sell rating, 8 hold … black hawk adult learning centerWebApr 12, 2024 · CRISPR Therapeutics Net Income Forecast for 2024 - 2025 - 2030. CRISPR Therapeutics's Net Income has decreased by 621.79% In the last year, from $66.86M to $-348.87M. In the next year, analysts predict that Net Income will jump to $-764.58M – up 119.16% from the current level. Looking ahead to ten years, experts forecast that Net … blackhawk advanced field operator watchWebCRISPR Therapeutics AG Common Shares (CRSP) Stock Price, Quote, News & History Nasdaq CRISPR Therapeutics AG Common Shares (CRSP) Nasdaq Listed Add to Watchlist Add to Portfolio... blackhawk adult learning centerWeb1 day ago · InvestorPlace - Stock Market News, Stock Advice & Trading Tips Against the backdrop of a solid day on Wall Street, CRISPR Therapeutics (NASDAQ: CRSP ) … black hawk adult chicken and rice 20kgWebReal time CRISPR Therapeutics (CRSP) stock price quote, stock graph, news & analysis. CRISPR Therapeutics (CRSP) Stock Price, News & Info The Motley Fool Please … black hawk adult lamb and rice 20kg